Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats

被引:9
作者
Kim, Tae Hwan [1 ]
Thapa, Subindra Kazi [2 ]
Lee, Da Young [3 ]
Chung, Seung Eun [3 ]
Lim, Jun Young [3 ]
Jeong, Hyeon Myeong [3 ]
Song, Chang Ho [3 ]
Choi, Youn-Woong [4 ]
Cho, Sang-Min [4 ]
Nam, Kyu-Yeol [4 ]
Kang, Won-Ho [4 ]
Shin, Soyoung [2 ]
Shin, Beom Soo [3 ]
机构
[1] Catholic Univ Daegu, Coll Pharm, Gyongsan 38430, Gyeongbuk, South Korea
[2] Wonkwang Univ, Coll Pharm, Iksan 54538, Jeonbuk, South Korea
[3] Sungkyunkwan Univ, Sch Pharm, Suwon 16419, Gyeonggi, South Korea
[4] Korea United Pharm Inc, Seoul 06116, South Korea
来源
PHARMACEUTICS | 2018年 / 10卷 / 03期
基金
新加坡国家研究基金会;
关键词
aceclofenac; diclofenac; esomeprazole; pharmacokinetics; gastric ulcer; NONSTEROIDAL ANTIINFLAMMATORY DRUG; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; COX-2; INHIBITORS; GASTRIC-ULCERS; CLINICAL-TRIAL; MULTICENTER; EFFICACY; OSTEOARTHRITIS;
D O I
10.3390/pharmaceutics10030152
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study examined the effects of esomeprazole on aceclofenac pharmacokinetics and gastrointestinal complications in rats. Aceclofenac alone, or in combination with esomeprazole, was orally administered to male Sprague-Dawley rats. Plasma concentrations of aceclofenac, its major metabolite diclofenac, and esomeprazole were simultaneously determined by a novel liquid chromatography-tandem mass spectrometry method. Gastrointestinal damage was determined by measuring ulcer area and ulcer lesion index of the stomach. Oral administration of aceclofenac induced significant gastric ulceration, which was inhibited by esomeprazole administration. Following concurrent administration of aceclofenac and esomeprazole, overall pharmacokinetic profiles of aceclofenac and metabolic conversion to diclofenac were unaffected by esomeprazole. Aceclofenac metabolism and pharmacokinetics were not subject to significant food effects, whereas bioavailability of esomeprazole decreased in fed compared to fasting conditions. In contrast, the pharmacokinetics of aceclofenac and esomeprazole were significantly altered by different dosing vehicles. These results suggest that co-administration of esomeprazole with aceclofenac may reduce aceclofenac-induced gastrointestinal complications without significant pharmacokinetic interactions. The optimal combination and clinical significance of the benefits of the combination of aceclofenac and esomeprazole need to be further evaluated.
引用
收藏
页数:15
相关论文
共 36 条
  • [1] Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers - Results of a double-blind, randomized, multicenter study
    Agrawal, NM
    Campbell, DR
    Safdi, MA
    Lukasik, NL
    Huang, B
    Haber, MM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) : 1455 - 1461
  • [2] Alcazar LFV, 1996, J RHEUMATOL, V23, P1194
  • [3] Andrade SF, 2006, Z NATURFORSCH C, V61, P329
  • [4] Ansah C., 2013, Ulcers, V2013, DOI [10.1155/2013/796405, DOI 10.1155/2013/796405]
  • [5] BatlleGualda E, 1996, J RHEUMATOL, V23, P1200
  • [6] Bort R, 1996, DRUG METAB DISPOS, V24, P969
  • [7] Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis
    Busquier, MP
    Calero, E
    Rodriguez, M
    Arce, PC
    Bermudez, A
    Linares, LF
    Mesa, J
    Crisostomos, CF
    Garcia, C
    Lopez, AG
    Valenzuela, A
    Povedano, A
    Perez, SG
    Lopez, MA
    Caliz, R
    Villalba, FG
    Cano, M
    Martinez, FG
    Gonzalez, J
    Caracuel, MA
    Roldan, R
    Ubeda, MG
    Gonzalez, A
    DelaFuente, ILM
    Rejon, E
    Sarabia, FN
    Prieto, J
    Gonzalez, J
    Rodriguez, JM
    Diaz, MR
    Manzano, F
    Perezbenegas, J
    Pou, MA
    [J]. CLINICAL RHEUMATOLOGY, 1997, 16 (02) : 154 - 159
  • [8] Diaz C., 1996, EUR J RHEUMATOL INFL, V16, P17
  • [9] Aceclofenac - A reappraisal of its use in the management of pain and rheumatic disease
    Dooley, M
    Spencer, CM
    Dunn, CJ
    [J]. DRUGS, 2001, 61 (09) : 1351 - 1378
  • [10] Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users
    Dries, A. M.
    Richardson, P.
    Cavazos, J.
    Abraham, N. S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (06) : 652 - 661